Skip to content

Study of Vidangadi guggulu and Chandanadi tail in wound patients

A Clinical study on Vidangadi Guggulu and Chandanadi taila in the management of vrana

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024004
Enrollment
40
Registered
2020-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T149- Unspecified injury

Interventions

Intervention1: Vidangadi guggulu and Chandanadi tail: Dose of Vidangadi guggulu -1gm twice in a day Route of administration- orally Route of administration of Chandanadi tail -locally Duration of the

Sponsors

Shree Narayan Prasad Awasthi Govt Ayurved College Raipur Chhattisgarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age between 18 â?? 60 years irrespective of gender, prakriti, religion etc . Patient having classical feature of vrana. Vrana within size of 7Ã?7cm2 or less Vrana in Diabetic patient with control sugar level. Dusta vrana with proper blood circulation and sensation. Postoperative wound w.s.r. to anal canal surgery.

Exclusion criteria

Exclusion criteria: 1. Patient below age of 18 and more than 60yrs. 2. Patient is not willing to participate in the trial. 3. Patient with disorder like leprotic ulcer, Tubercular ulcer, osteomylitis 4. Patient with HIV , HBsAg, VDRL positive. 5. Infected malignant ulcer , ischemic ulcer, gangrene. 6. Patient having known allergy to trial drug. 7. Vrana in visceral ,bony , spinal injuries. 8. Pregnancy. 9. Burn cases

Design outcomes

Secondary

MeasureTime frame
To improve quality of lifeTimepoint: 1 month

Primary

MeasureTime frame
To increase healing process of wound and prevent from microbial agentTimepoint: 1 month

Countries

India

Contacts

Public ContactDr Balendra singh

Shree Narayan Prasad Awasthi government ayurved college raipur chhattisgarh

druk01508@gmail.com8234057199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026